Penserra Capital Management LLC Alector, Inc. Transaction History

Penserra Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$19.35 - $25.54 $35,797 - $47,249	-1,850 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$21.65 - $39.49 $757 - $1,382	35 Added 1.93%	1,850 $42,000
Q2 2021 Aug 12, 2021	BUY	$15.5 - $22.48 $232 - $337	15 Added 0.83%	1,815 $37,000
Q1 2021 May 13, 2021	SELL	$14.84 - $22.23 $593 - $889	-40 Reduced 2.17%	1,800 $36,000
Q4 2020 Feb 12, 2021	BUY	$9.4 - $16.7 $10,941 - $19,438	1,164 Added 172.19%	1,840 $27,000
Q3 2020 Nov 13, 2020	BUY	$10.54 - $24.96 $7,125 - $16,872	676 New	676 $7,000

168

57.8M

146K

90.8K

Ticker ALEC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,563,904
Market Cap $159M
Description
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.